Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Lipocine Inc.
The latest drug development news and highlights from the Pink Sheet FDA Performance Tracker.
Keeping Track Of User Fee Decisions And Filings: Adakveo, Brukinsa And Fetroja Mark Massive Week Of Novel Approvals
The latest news on US FDA user fee decisions and submissions to the agency.
The latest drug development news and highlights from our US FDA Performance Tracker.
Studies are unfeasible, sponsors argue in advance of US advisory committee meeting that could lead to FDA ending its waiver on requiring clinical trials in pediatric patients for new testosterone replacement therapy products.
- Specialty Pharmaceuticals
- Controlled Release
- Large Molecule
Drug Discovery Tools